NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
63 hedge funds and large institutions have $10.7M invested in Navidea Biopharmaceuticals Inc. in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
77% less capital invested
Capital invested by funds: $46.7M → $10.7M (-$36M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
63
Holding in Top 10
–
Calls
$13K
Puts
$42K
Top Buyers
| 1 | +$723K | |
| 2 | +$396K | |
| 3 | +$358K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$297K |
| 5 |
LCM
Laurion Capital Management
New York
|
+$233K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$1.1M | |
| 3 | -$1.07M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$705K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$666K |